[EN] AZAINDOLE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE L'AZAINDOLE KINASE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2004009601A1
公开(公告)日:2004-01-29
The present invention provides compounds of formula (I), (I) and pharmaceutically acceptable salts thereof.The formula I compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2 and FGFR-1, thereby making them useful as anti-cancer agents. The formula (I) compounds are also useful for the treatment of other diseases associated with signal transduction pathways operating through growth factor receptors.